Compounds > telbivudine
Page last updated: 2024-09-04

telbivudine and vildagliptin

telbivudine has been researched along with vildagliptin in 2 studies

Compound Research Comparison

Studies
(telbivudine)		Trials
(telbivudine)		Recent Studies (post-2010)
(telbivudine)		Studies
(vildagliptin)		Trials
(vildagliptin)		Recent Studies (post-2010) (vildagliptin)
48685332793186566

Protein Interaction Comparison

ProteinTaxonomytelbivudine (IC50)vildagliptin (IC50)
Dipeptidyl peptidase 9Bos taurus (cattle)0.68
Dipeptidyl peptidase IVPorphyromonas gingivalis1.3
Dipeptidyl peptidase 4Homo sapiens (human)0.1496
Dipeptidyl peptidase 4Mus musculus (house mouse)0.051
Prolyl endopeptidase FAPHomo sapiens (human)2.497
Dipeptidyl peptidase 8Homo sapiens (human)3.0627
Dipeptidyl peptidase 9Homo sapiens (human)0.4224
Dipeptidyl peptidase 2Homo sapiens (human)0.051

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

2 other study(ies) available for telbivudine and vildagliptin

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023